21 CFR Part 312
INVESTIGATIONAL NEW DRUG APPLICATION
June 25, 2020
Subpart
E
Drugs Intended to Treat Life-threatening and Severely-debilitating Illnesses
Subpart
A
General Provisions
Subpart
B
Investigational New Drug Application (IND)
Subpart
C
Administrative Actions
Subpart
D
Responsibilities of Sponsors and Investigators
Subpart
F
Miscellaneous
Subpart
G
Drugs for Investigational Use in Laboratory Research Animals or In Vitro Tests
Subpart
H
[Reserved]
Subpart
I
Expanded Access to Investigational Drugs for Treatment Use